aTyr Pharma, Inc. (ATYR)
NASDAQ: ATYR · Real-Time Price · USD
4.320
-0.110 (-2.48%)
At close: Feb 21, 2025, 4:00 PM
4.466
+0.146 (3.37%)
After-hours: Feb 21, 2025, 7:49 PM EST
aTyr Pharma Analyst Ratings
Total Analysts
6
Consensus Rating
Strong Buy
Price Target
$18.60
Upside
+330.56%
Ratings History
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Initiates $16 | Buy | Initiates | $16 | +270.37% | Feb 18, 2025 |
Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Jan 6, 2025 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +710.19% | Dec 10, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +710.19% | Dec 3, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +710.19% | Oct 29, 2024 |
Wells Fargo | Wells Fargo | Buy Initiates $17 | Buy | Initiates | $17 | +293.52% | Oct 4, 2024 |
Jefferies | Jefferies | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +108.33% | Sep 5, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +710.19% | Aug 15, 2024 |
RBC Capital | RBC Capital | Buy Reiterates $16 | Buy | Reiterates | $16 | +270.37% | Aug 14, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +710.19% | Aug 1, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $35 | Strong Buy | Reiterates | $35 | +710.19% | Jul 22, 2024 |